These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8404307

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C, Huang R, Lian L.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of Ip cisplatin in refractory ovarian carcinoma.
    Pretorius RG, Hacker NF, Berek JS, Ford LC, Hoeschele JD, Butler TA, Lagasse LD.
    Cancer Treat Rep; 1983 Dec; 67(12):1085-92. PubMed ID: 6228294
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy.
    Panteix G, Beaujard A, Garbit F, Chaduiron-Faye C, Guillaumont M, Gilly F, Baltassat P, Bressolle F.
    Anticancer Res; 2002 Dec; 22(2B):1329-36. PubMed ID: 12168946
    [Abstract] [Full Text] [Related]

  • 6. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetics study of intraperitoneal carboplatin in gynecologic carcinoma].
    Tu C, Meng Y, Yang X.
    Zhonghua Fu Chan Ke Za Zhi; 1995 Apr; 30(4):212-4. PubMed ID: 7664606
    [Abstract] [Full Text] [Related]

  • 8. Regional pharmacokinetic selectivity of intraperitoneal cisplatin in ovarian cancer.
    Esposito M, Campora E, Repetto M, Fulco RA, Simoni GA, Falcone A, Collecchi P, Gogioso L, Nobile MT, Civalleri D.
    Oncology; 1988 Apr; 45(2):69-73. PubMed ID: 3353075
    [Abstract] [Full Text] [Related]

  • 9. [Intraperitoneal chemotherapy for ovarian adenocarcinoma: pharmacokinetics of cisplatin].
    Ravina JH, Szyller A, Mintz P, Ferrand S, Ciraru-Vigneron N, Zylberberg B, Bourdon R, Galliot M.
    J Gynecol Obstet Biol Reprod (Paris); 1992 Apr; 21(2):193-7. PubMed ID: 1583298
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacokinetics of cisplatin in long-term hemodialysis treatment].
    Sturn W, Sanwald R, Ehninger G.
    Dtsch Med Wochenschr; 1989 Mar 03; 114(9):337-9. PubMed ID: 2920679
    [Abstract] [Full Text] [Related]

  • 11. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
    Sugiyama T, Kumagai S, Nishida T, Ushijima K, Matsuo T, Yakushiji M, Hyon SH, Ikada Y.
    Anticancer Res; 1998 Mar 03; 18(4B):2837-42. PubMed ID: 9713471
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
    Fracasso ME, Apostoli P, Benoni G, Bonetti A, Griso C, Leone R.
    Drugs Exp Clin Res; 1987 Mar 03; 13(6):367-72. PubMed ID: 3652926
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS, Kanekal S, Lin XR, Leung TW, Chan AT, Yeo W, Yu S, Chak K, Leavitt R, Johnson P.
    Cancer; 2001 Jun 15; 91(12):2369-77. PubMed ID: 11413527
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of carboplatin after i.v. administration.
    Elferink F, van der Vijgh WJ, Klein I, Vermorken JB, Gall HE, Pinedo HM.
    Cancer Treat Rep; 1987 Dec 15; 71(12):1231-7. PubMed ID: 3319135
    [Abstract] [Full Text] [Related]

  • 15. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
    Noda T, Oku M, Kiyozuka Y, Ninomiya Y, Hino K, Okamura Y, Maruyama M, Ichijo M.
    Gan To Kagaku Ryoho; 1987 Apr 15; 14(4):1025-32. PubMed ID: 3566301
    [Abstract] [Full Text] [Related]

  • 16. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
    Kern W, Braess J, Kotschofsky M, Samel S, Becker H, Hiddemann W, Schleyer E.
    Anticancer Res; 2002 Apr 15; 22(5):3099-102. PubMed ID: 12530050
    [Abstract] [Full Text] [Related]

  • 17. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
    Royer B, Delroeux D, Guardiola E, Combe M, Hoizey G, Montange D, Kantelip JP, Chauffert B, Heyd B, Pivot X.
    Cancer Chemother Pharmacol; 2008 Mar 15; 61(3):415-21. PubMed ID: 17503047
    [Abstract] [Full Text] [Related]

  • 18. Plasma and tumor concentrations of cisplatin following intraperitoneal infusion or bolus injection with or without continuous low-dose-rate irradiation.
    Fu KK, DeGregorio MW, Phillips JW.
    NCI Monogr; 1988 Mar 15; (6):123-7. PubMed ID: 3281027
    [Abstract] [Full Text] [Related]

  • 19. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
    Hirashima Y, Shimura T, Tanaka Y, Demukai H, Kubota T, Kobayashi T, Suzuki A.
    Gan To Kagaku Ryoho; 1993 Aug 15; 20(10):1321-6. PubMed ID: 8346930
    [Abstract] [Full Text] [Related]

  • 20. Clinical pharmacology of intraperitoneal cisplatin.
    Lopez JA, Krikorian JG, Reich SD, Smyth RD, Lee FH, Issell BF.
    Gynecol Oncol; 1985 Jan 15; 20(1):1-9. PubMed ID: 4038390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.